Michalina Justyna Kozłowska

Michalina Justyna Kozłowska

Auto-generated profile, based on publicly available information

Michalina Justyna Kozłowska

Pomeranian Medical University, Szczecin, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MKMichalina Kozłowska
Michalina Kozłowska
MMMaciej Kamil Majchrzak
Maciej Kamil Majchrzak
FKFaustyna Magdalena Kołodziej
Faustyna Magdalena Kołodziej
AKAlicja Kwiatkowska
Alicja Kwiatkowska
JJJakub Juskowiak
Jakub Juskowiak
KKKrzysztof Konopka
Krzysztof Konopka
Background: Suicide remains a critical global public health crisis, demanding proactive intervention strategies. Recent advancements in artificial intelligence (AI), including machine learning and natural language processing, offer unprecedented capabilities for early suicide risk prediction utilizing electronic health records, clinical notes, and digital phenotyping. Objective: This structured review evaluates current evidence regarding the performance of AI models in predicting suicide risk, analyzes the ethical challenges associated with their deployment, and identifies primary barriers and facilitators to successful clinical implementation. Methodology: A structured literature search was conducted utilizing PubMed/MEDLINE and Google Scholar for peer-reviewed articles published between 2018 and 2026. Following specific inclusion and exclusion criteria, the final corpus of studies was analyzed using a thematic synthesis framework focusing on predictive accuracy, ethical implications, and workflow integration. Results: While AI algorithms frequently demonstrate robust predictive accuracy, their clinical utility is heavily complicated by significant ethical and operational hurdles. Key challenges include algorithmic bias exacerbating health inequities, severe data privacy concerns, and a notable lack of clinician trust stemming from the "black box" nature of complex machine learning models. Furthermore, poor integration into existing psychiatric workflows limits real-world feasibility. Conclusion: AI represents a powerful, yet imperfect, socio-technical tool for suicide prevention. Bridging the translational gap from algorithmic validation to routine clinical use requires rigorous ethical governance, prioritized model explainability, and human-centered implementation strategies tailored to frontline healthcare settings.

14 October 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MMMaciej Kamil Majchrzak
Maciej Kamil Majchrzak
FKFaustyna Magdalena Kołodziej
Faustyna Magdalena Kołodziej
KKKrzysztof Konopka
Krzysztof Konopka
MLMateusz Lis
Mateusz Lis
ZKZuzanna Julia Komin
Zuzanna Julia Komin
MKMichalina Justyna Kozłowska
Michalina Justyna Kozłowska
Background: Hospital readmission rates are often used to judge the quality of care and how well healthcare systems are working. Predictive models based on electronic health records (EHRs) can help estimate which patients are at higher risk, but when they don’t properly reflect socioeconomic realities, they can unintentionally reinforce existing inequalities (Obermeyer et al., 2019). This review looks at how well these EHR-based models predict 30-day readmissions, how Social Determinants of Health (SDOH) are included, and what this means for fairness and health equity in real-world use. Methodology: A structured literature review was conducted using PubMed/MEDLINE and Google Scholar. It included peer-reviewed studies published between 2018 and 2026, focusing on model validation studies, retrospective cohort analyses, and research on bias and fairness in predictive healthcare models. Results: Synthesis reveals that incorporating unstructured and structured SDOH variables yields mixed impacts on discriminatory performance (Area Under the Receiver Operating Characteristic curve changes ranging from -0.01 to +0.04), yet significantly rectifies systemic algorithmic underestimation of risk for marginalized demographics. Unadjusted models consistently show racial, ethnic, and socioeconomic bias, often because they rely on proxy variables embedded in historical healthcare data (Gianfrancesco et al., 2018). As a result, preventive transition-of-care resources can be systematically directed away from the patients who need them most (Pierson et al., 2021). Conclusion: To make predictive healthcare tools truly useful in practice, it is not enough to focus only on accuracy. They also need to account for fairness, real clinical context, and the actual consequences of their use in everyday healthcare settings (Wiens et al., 2019). Policy-level interventions must mandate standardized SDOH extraction alongside equity-focused calibration algorithms before widespread clinical deployment (Ghassemi et al., 2021).

5 October 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ZKZuzanna Julia Komin
Zuzanna Julia Komin
EKEliza Zofia Kabat
Eliza Zofia Kabat
MKMichalina Justyna Kozłowska
Michalina Justyna Kozłowska
KKKrzysztof Konopka
Krzysztof Konopka
MMMaciej Kamil Majchrzak
Maciej Kamil Majchrzak
MLMaryan Liasota
Maryan Liasota
Background: Sepsis remains a primary cause of mortality and organ dysfunction in Intensive Care Units (ICUs) globally. Although AI models show considerable promise for the early identification of sepsis, moving these tools from retrospective performance to bedside utility is hindered by socio-technical barriers, workflow friction, and algorithmic equity issues. Objective: This structured review evaluates the state of AI-driven sepsis Early Warning Systems (EWS), identifying systemic barriers to clinical integration and assessing algorithmic fairness across demographic cohorts. Methodology: A structured review of peer-reviewed literature published in PubMed/MEDLINE and Google Scholar between January 2018 and June 2026 was conducted, focusing on predictive performance, clinical implementation, and algorithmic equity. Results: Retrospective assessments of deep sequential architectures demonstrate high diagnostic accuracy (AUROC>0.95) (Boussina et al., 2024; Siddiqui, 2026). Prospective trials of landmark systems such as TREWS (Adams et al., 2022), COMPOSER (Shashikumar et al., 2025), and CONCERN EWS (Rossetti et al., 2025), confirm clinical utility, yielding mortality reductions of 17% to 35.6%. However, real-world effectiveness is frequently hindered by severe alert fatigue (Wong et al., 2021). Furthermore, because models rely on historical health data, they often inherit systemic biases, risking the exacerbation of existing disparities related to race, gender and socioeconomic status (Chen et al., 2023; Obermeyer et al., 2019; Seyyed-Kalantari et al., 2021). Conclusion: Maximizing the clinical impact of AI-driven EWS requires a paradigm shift from purely performance-centric model development to rigorous, equity-oriented clinical governance guided by international reporting frameworks like TRIPOD-AI (Collins et al., 2024) and DECIDE-AI (Vasey et al., 2022). To operationalize this, we propose the integration of the Clinical AI Safety Officer (CAISO) to maintain real-time algorithmic safety, audit demographic equity, and manage the clinical accountability loop.

14 October 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JJJakub Juskowiak
Jakub Juskowiak
ZKZuzanna Julia Komin
Zuzanna Julia Komin
MLMaryan Liasota
Maryan Liasota
EKEliza Zofia Kabat
Eliza Zofia Kabat
MKMichalina Justyna Kozłowska
Michalina Justyna Kozłowska
MLMateusz Lis
Mateusz Lis
Background Clinical-grade wearable biosensors offer significant potential for tracking chronic diseases outside the hospital. However, while the hardware itself is highly accurate, the medical field still struggles with the logistical reality of deploying these tools. The structural barriers preventing widespread clinical use, and the ways these hurdles impact overall health equity, lack rigorous synthesis in the current literature. Objective Moving beyond pure hardware accuracy, this analysis maps the practical realities of continuous patient surveillance. It specifically investigates the institutional workflow bottlenecks, hardware usability hurdles, and underlying economic disparities that dictate how monitoring programs actually function for populations managing heart failure, diabetes, or COPD. Methodology Peer-reviewed literature spanning 2018 to 2026 was extracted from PubMed/MEDLINE and Google Scholar. The inclusion criteria deliberately filtered out purely technical validation studies. Instead, the analysis targeted data documenting the logistical friction, long-term adherence failures, and unequal access surrounding continuous glucose monitors, ambulatory cardiac patches, and multi-parameter tracking devices. Results The synthesized data show that severe workflow friction and poor electronic health record interoperability actively block hospital networks from scaling these programs. On the patient side, a distinct "compliance paradox" emerges. High initial motivation frequently collapses into device abandonment, usually triggered by physical skin irritation, convoluted software interfaces, and low technical literacy. The literature also exposes a severe digital divide. A patient's income bracket, geographic location, and advanced age strictly gatekeep their ability to access continuous medical monitoring. Conclusion Healthcare networks cannot rely solely on precise hardware to improve chronic disease management. Deploying continuous monitors successfully requires a fundamental shift toward repairing broken clinical workflows and addressing systemic exclusion. Without structural interventions targeting financial and technical accessibility, digital health initiatives will simply reinforce existing medical inequalities.

26 October 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
AKAlicja Kwiatkowska
Alicja Kwiatkowska
FKFaustyna Magdalena Kołodziej
Faustyna Magdalena Kołodziej
MMMaciej Kamil Majchrzak
Maciej Kamil Majchrzak
KKKrzysztof Konopka
Krzysztof Konopka
MKMichalina Justyna Kozłowska
Michalina Justyna Kozłowska
JJJakub Juskowiak
Jakub Juskowiak
Background: The intersection of a global psychiatric workforce shortage and the rapid advancement of Generative Artificial Intelligence (GenAI) has catalyzed the integration of Large Language Models (LLMs) into digital healthcare. LLMs are increasingly deployed as preliminary triage agents to assess psychological distress, yet their diagnostic reliability, demographic neutrality, and safety protocols in crisis scenarios remain heavily debated within the psychiatric community. Objective: This review evaluates current research to determine the trustworthiness of large language models (LLMs) used in psychiatric screening. In doing so, it shines a light on the algorithmic biases present in practical use and maps out the necessary ethical standards to ensure digital health services remain safe and fair for all patients. Methodology: We sourced peer-reviewed publications released between 2023 and 2026 by running a systematic literature search across Google Scholar, PubMed/MEDLINE, and IEEE Xplore. The synthesis focused on comparative accuracy studies, observational evaluations, and sociotechnical analyses of leading LLMs (e.g., GPT-4, Claude 3.5 Sonnet, Gemini 1.5 Pro) applied specifically to psychiatric screening and automated clinical routing. Results: LLMs demonstrate high diagnostic concordance with human clinicians in structured assessments for high-prevalence conditions like major depressive disorder, effectively parsing unstructured clinical narratives. However, they exhibit a consistent tendency toward conservative over-triage in psychiatric emergencies. Profound algorithmic biases persist; models frequently recommend divergent, often inferior, treatment pathways for marginalized demographic groups and display gender-based stigmatization. Furthermore, models struggle with complex psychopathologies and display inconsistent safety mechanisms during acute suicidal ideation queries. Conclusion: While LLMs offer substantial utility for scaling preliminary psychiatric screening and reducing administrative triage burdens, their propensity for factual hallucination, demographic bias, and uncalibrated risk escalation currently precludes autonomous clinical deployment. Robust, human-in-the-loop governance and culturally representative training corpora are imperative prior to further integration into global digital health ecosystems.

5 October 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KKKrzysztof Konopka
Krzysztof Konopka
MKMichalina Justyna Kozłowska
Michalina Justyna Kozłowska
EKEliza Zofia Kabat
Eliza Zofia Kabat
MLMaryan Liasota
Maryan Liasota
ZKZuzanna Julia Komin
Zuzanna Julia Komin
MMMaciej Kamil Majchrzak
Maciej Kamil Majchrzak
Background: Chatbots are increasingly used to deliver cognitive behavioural therapy (CBT) via mobile and web applications. Many mental health systems cannot meet demand with face-to-face care alone. CBT chatbots have therefore been introduced in app form, but data on outcomes, dropout, and unequal uptake remain limited. Objective: This review evaluates whether CBT chatbots reduce anxiety and depression symptoms, which user- and design-related factors are linked to engagement and dropout, and which structural barriers limit who can practically use these tools. Methodology: Peer-reviewed studies from 2018 to 2026 were identified through searches in PubMed/MEDLINE and Google Scholar. Included studies examined automated CBT chatbots (e.g., Woebot, Wysa, Youper, Limbic Care) and reported clinical outcomes, engagement or dropout, and/or access-related findings. Twenty-four publications were synthesised thematically. Results: Short-term trials and observational studies reported reductions in anxiety and depression symptoms, with small-to-moderate effects1. Generative conversational designs were linked to higher engagement than static digital programmes in at least one RCT, which reported roughly 2.4 times the use frequency of a generative CBT app relative to workbook controls3. Attrition remained notable; one meta-analysis estimated intervention-arm dropout at 21.84%5. Unequal access persisted because of connectivity, device availability, and digital literacy, despite the privacy and round-the-clock availability of app-based care23. Conclusion: CBT chatbots may serve as useful low-intensity interventions, but their public health value depends on improved retention and fairer access. Implementation should address digital literacy, culturally appropriate design, and governance that does not restrict validated tools to already advantaged users.